Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Jan Beyer-Westendorf

51-100 of 132 results

Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs

scientific article published on 16 February 2017

Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism

scientific article published on 8 March 2018

Outpatient or inpatient treatment for acute pulmonary embolism: a retrospective cohort study of 439 consecutive patients

scientific article published on July 1, 2015

Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism

scientific article published on 01 October 2018

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

scientific article published on 05 November 2019

Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial

scientific article published in January 2020

Direct Oral Anticoagulants and Women

scientific article

Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population-based cohort study

scientific article published on 07 September 2018

Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting.

scientific article published on 12 April 2018

What have we learned from real-world NOAC studies in venous thromboembolism treatment?

scientific article

Development of Recommendations to Continue Anticoagulation with One of the Two Types of Oral Anticoagulants Based on the Identification of Patients' Preference

scientific article published on February 19, 2015

Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies

scientific article published on 13 August 2019

Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis

scholarly article by Marco Senzolo et al published 15 August 2018 in Clinical and translational gastroenterology

Venous thromboembolism therapy with rivaroxaban in daily-care patients: Results from the Dresden NOAC registry

scientific article published on 01 April 2018

Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials

scientific article published on 21 November 2016

Superficial vein thrombosis treated for 45 days with rivaroxaban versus fondaparinux: rationale and design of the SURPRISE trial

scientific article published on 01 August 2016

Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr Phase 3 dose-exposure-response evaluation

scientific article published on 04 April 2020

Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetes

scientific article published on 11 June 2019

The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney disease

scientific article published in February 2018

Effectiveness and safety of apixaban therapy in daily-care patients with atrial fibrillation: results from the Dresden NOAC Registry

scientific article published on 22 June 2017

Once- versus twice-daily direct oral anticoagulants in non-valvular atrial fibrillation

scientific article published on 11 August 2017

The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients

scientific article published on 15 August 2018

Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial

scientific article published on 18 December 2018

Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism.

scientific article published in January 2018

Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients

scientific article published on 27 December 2019

Efficacy and safety of venous thromboembolism prophylaxis with apixaban in major orthopedic surgery

scientific article published on March 23, 2012

Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy‐resistant venous thrombosis treated with dabigatran and fondaparinux

scientific article published on October 1, 2011

Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous Thromboembolism

article published in 2019

Small clots with large impact

scientific article published on August 20, 2015

Increase of Gastrointestinal Bleeding With New Oral Anticoagulants: Problems of a Meta-analysis

scientific article published on September 24, 2013

COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study

Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study

scientific article published on 30 May 2018

Controversies in venous thromboembolism: to treat or not to treat superficial vein thrombosis

scientific article published in December 2017

Health-care Cost Impact of Continued Anticoagulation With Rivaroxaban vs Aspirin for Prevention of Recurrent Symptomatic VTE in the EINSTEIN-CHOICE Trial Population

scientific article published on 07 September 2018

A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients

scientific article published on 24 October 2016

Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin

scientific article published on 10 July 2018

New oral anticoagulants and endoscopy--what do you have to consider?

scientific article published on August 11, 2015

Coagulation activation after discontinuation of VTE treatment with different oral anticoagulants and impact on 12-month clinical outcomes

scientific article published on June 10, 2015

Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill

scholarly article by Benjamin Brenner et al published 15 April 2019 in Thrombosis journal

Cancer in males and risk of venous thromboembolism

scientific article published on April 2010

Sex hormones and venous thromboembolism – from contraception to hormone replacement therapy

scientific article published on 16 July 2018

Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry

Comparative Risk of Major Bleeding with Rivaroxaban and Warfarin: Population Based Cohort Study of Unprovoked Venous Thromboembolism

scientific article published on 20 November 2018

Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery – findings from the ORTHO‐TEP registry

scientific article published on December 1, 2012

DOACS in women: pros and cons

scientific article published on 01 September 2019

Predictors of deep venous thrombosis in patients admitted to rehabilitation clinics after major orthopaedic surgery

scientific article published on January 1, 2013

Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine-A Multicenter Trial

scientific article published on 08 November 2019

Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTE

scientific article published on 07 February 2019

Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation

scientific article published on 01 July 2020

[Bleeding complications under oral anticoagulation]

scientific article published on February 6, 2015